The secondary structure analysis of a potent Ser14Gly analog of antiAlzheimer peptide, Humanin, by circular dichroism
- PMID: 16835886
- DOI: 10.1002/psc.773
The secondary structure analysis of a potent Ser14Gly analog of antiAlzheimer peptide, Humanin, by circular dichroism
Abstract
The structure of a highly potent Ser14Gly analog of antiAlzheimer peptide, Humanin, was examined by circular dichroism (CD). The secondary structure is more disordered in water than in phosphate-buffered saline (PBS). The peptide structure in water is little dependent on both peptide concentration and temperature. On the contrary, the peptide structure was significantly different in PBS from the structure in water, which is more apparent at a higher peptide concentration and temperature. The observed different structure in PBS appears to be due to self-association of the peptide, which is enhanced by elevated temperature and, hence, via hydrophobic interactions. The wild-type Humanin also behaved similarly, i.e., it assumed a disordered structure in water but underwent conformational changes in PBS. Although high peptide concentrations for CD measurements are not encountered in vivo, the results suggest the tendency of the peptide to interact hydrophobically with other structures as well as with itself.
Copyright 2006 European Peptide Society and John Wiley & Sons, Ltd.
Similar articles
-
The structure analysis of Humanin analog, AGA-(C8R)HNG17, by circular dichroism and sedimentation equilibrium: comparison with the parent molecule.Int J Biol Macromol. 2008 Aug 15;43(2):88-93. doi: 10.1016/j.ijbiomac.2008.03.007. Epub 2008 Apr 1. Int J Biol Macromol. 2008. PMID: 18456318
-
Solution structure of Ser14Gly-humanin, a potent rescue factor against neuronal cell death in Alzheimer's disease.Biochem Biophys Res Commun. 2006 Oct 20;349(2):634-42. doi: 10.1016/j.bbrc.2006.08.087. Epub 2006 Aug 23. Biochem Biophys Res Commun. 2006. PMID: 16945331
-
Activity-dependent neurotrophic factor, ADNF, determines the structure characteristics of Colivelin, a fusion protein of ADNF9 and Humanin analog.J Pept Sci. 2008 May;14(5):631-6. doi: 10.1002/psc.959. J Pept Sci. 2008. PMID: 17994638
-
[Disruption of protein structure in the current CD measurement].Tanpakushitsu Kakusan Koso. 1994 Dec;39(16):2837-41. Tanpakushitsu Kakusan Koso. 1994. PMID: 7855305 Review. Japanese. No abstract available.
-
Structural information on proteins from circular dichroism spectroscopy possibilities and limitations.Pharm Biotechnol. 1995;7:65-100. doi: 10.1007/978-1-4899-1079-0_2. Pharm Biotechnol. 1995. PMID: 8564023 Review. No abstract available.
Cited by
-
Potent humanin analog increases glucose-stimulated insulin secretion through enhanced metabolism in the β cell.FASEB J. 2013 Dec;27(12):4890-8. doi: 10.1096/fj.13-231092. Epub 2013 Aug 30. FASEB J. 2013. PMID: 23995290 Free PMC article.
-
Sandwiched-fusion strategy facilitates recombinant production of small labile proteins.Protein Sci. 2021 Mar;30(3):650-662. doi: 10.1002/pro.4024. Epub 2021 Jan 29. Protein Sci. 2021. PMID: 33433908 Free PMC article.
-
Humanin and age-related diseases: a new link?Front Endocrinol (Lausanne). 2014 Dec 4;5:210. doi: 10.3389/fendo.2014.00210. eCollection 2014. Front Endocrinol (Lausanne). 2014. PMID: 25538685 Free PMC article. Review.
-
Humanin induces conformational changes in the apoptosis regulator BAX and sequesters it into fibers, preventing mitochondrial outer-membrane permeabilization.J Biol Chem. 2019 Dec 13;294(50):19055-19065. doi: 10.1074/jbc.RA119.011297. Epub 2019 Nov 5. J Biol Chem. 2019. PMID: 31690630 Free PMC article.
-
Mapping the specific cytoprotective interaction of humanin with the pro-apoptotic protein bid.Chem Biol Drug Des. 2007 Nov;70(5):383-92. doi: 10.1111/j.1747-0285.2007.00576.x. Epub 2007 Oct 10. Chem Biol Drug Des. 2007. PMID: 17927731 Free PMC article.